GlassScriptPhysician profile
Brady H Burge
NPI 1013347707
$12,234.80
in general payments reported to CMS, 2019-2025
53 companies · $2,792 in 2025
The $2,792 reported for 2025 was more than what 97% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,805 · 2022: $2,477 · 2023: $2,440 · 2024: $2,720 · 2025: $2,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,920 · Education: $32.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,920.26 |
| Education | $32.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,942.37 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,452.60 | 2021-2025 | |
| Eisai INC. | $898.66 | 2021-2025 | |
| Sk Life Science, INC. | $732.29 | 2021-2025 | |
| Lundbeck LLC | $704.71 | 2023-2025 | Vyepti, Rexulti |
| Acadia Pharmaceuticals INC | $505.96 | 2021-2025 | Nuplazid |
| Ucb, INC. | $467.16 | 2021-2025 | Zilbrysq, Briviact, Rystiggo |
| Argenx US, INC. | $376.04 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Pfizer INC. | $359.48 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $318.45 | 2022-2025 | Austedo Xr, Austedo Xr |
| Lilly USA, LLC | $295.58 | 2022-2025 | Amyvid, Emgality, Kisunla |
| Celgene Corporation | $277.86 | 2022-2024 | Zeposia |
| Biohaven Pharmaceutical Holding Company LTD. | $269.92 | 2022 | |
| Impel Pharmaceuticals INC. | $269.59 | 2022-2023 | Trudhesa |
| Amgen INC. | $196.79 | 2021-2025 | Aimovig |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $178.18 | 2023-2025 | Rexulti, Nuedexta |
| Neurocrine Biosciences, INC. | $153.14 | 2021-2025 | Ingrezza, Ongentys |
| Axsome Therapeutics, INC. | $142.56 | 2025 | Symbravo |
| Mdd US Operations, LLC | $134.20 | 2022-2024 | Gocovri, Xadago, Apokyn |
| Acorda Therapeutics, INC | $129.76 | 2021-2024 | Inbrija |
| Biogen, INC. | $116.88 | 2021-2025 | Vumerity, Tysabri |
| Emd Serono, INC. | $94.01 | 2024 | |
| Alexion Pharmaceuticals, INC. | $86.55 | 2022-2023 | Ultomiris, Soliris |
| Genzyme Corporation | $75.35 | 2022-2025 | |
| Grifols USA, LLC | $66.80 | 2022-2024 | Gamunex-C |
| Alnylam Pharmaceuticals INC. | $64.42 | 2023 | Amvuttra |
| Catalyst Pharmaceuticals, INC. | $63.23 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $55.06 | 2021-2022 | |
| Janssen Biotech, INC. | $54.65 | 2025 | |
| Tanabe Pharma America, INC. | $52.34 | 2021-2024 | |
| Supernus Pharmaceuticals, INC. | $51.31 | 2021-2022 | |
| Life Molecular Imaging LTD | $47.16 | 2024 | Neuraceq |
| Janssen Pharmaceuticals, INC | $46.62 | 2022-2023 | Ponvory |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.90 | 2021-2023 | Relistor |
| Medtronic, INC. | $42.58 | 2024-2025 | Percept PC Brainsense |
| Neurelis, INC. | $42.00 | 2024-2025 | Valtoco |
| Ani Pharmaceuticals, INC. | $37.31 | 2023 | Purified Cortrophin Gel |
| Ipsen Biopharmaceuticals, INC | $35.64 | 2023 | Dysport |
| Sobi, INC | $35.47 | 2024 | |
| Arbor Pharmaceuticals, INC. | $34.57 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $32.65 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $31.43 | 2022-2023 | |
| Kedrion Biopharma, INC. | $30.32 | 2025 | Albuked, Koate, Rhogam Ultra-Filtered Plus |
| Octapharma USA, INC. | $24.49 | 2024 | Panzyga |
| Adamas Pharmaceuticals, INC. | $23.82 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.21 | 2024 | Hyqvia |
| Scilex Pharmaceuticals INC. | $21.44 | 2023 | Ztlido |
| Idorsia Pharmaceuticals US INC | $19.60 | 2022 | |
| Jazz Pharmaceuticals INC. | $17.58 | 2022 | |
| Averitas Pharma INC. | $15.81 | 2024 | Qutenza |
| Inspiremd LTD | $15.18 | 2025 | Cguard Prime Carotid Stent System |
| Upsher-Smith Laboratories LLC | $15.04 | 2021 | |
| Azurity Pharmaceuticals, INC. | $13.08 | 2024 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brady Burge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.